(0)

Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Capital Hilton

28 oct 2024 8:30 a.m. - 30 oct 2024 12:40 p.m.

1001 16th Street NW, Washington, DC 20036-5794

DIA/FDA Oligonucleotide-Based Therapeutics Conference

CONTACT US
Send Email 1.888.257.6457

Volver a Agenda

Oligonucleotide Safety Working Group (OSWG) – Open Meeting

Session Chair(s)

Jeffrey Foy, PHD

Jeffrey Foy, PHD

Executive Director, Toxicology

Nimbus Therapeutics, United States

Oligonucleotide Safety Working Group (OSWG) – Open Meeting

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.